-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Alzamend Neuro, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q2 2024.
- Alzamend Neuro, Inc. Nonoperating Income (Expense) for the quarter ending July 31, 2024 was -$12K, a 554% decline year-over-year.
- Alzamend Neuro, Inc. Nonoperating Income (Expense) for the twelve months ending July 31, 2024 was -$20.3K, a 153% decline year-over-year.
- Alzamend Neuro, Inc. annual Nonoperating Income (Expense) for 2023 was -$10.1K, a 31.2% decline from 2022.
- Alzamend Neuro, Inc. annual Nonoperating Income (Expense) for 2022 was -$7.7K, a 81.9% increase from 2021.
- Alzamend Neuro, Inc. annual Nonoperating Income (Expense) for 2021 was -$42.5K, a 55.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)